We are live on ! Find out more
NFGH

Nan Fung Group Holdings Portfolio holdings

AUM $121M
1-Year Est. Return 56.89%
This Fund
S&P 500
This Quarter Est. Return
-14.02%
1 Year Est. Return
+56.89%
3 Year Est. Return
+244.35%
5 Year Est. Return
+210.19%
10 Year Est. Return
–
AUM
$123M
AUM Growth
-$33M
Cap. Flow
-$6.88M
Cap. Flow %
-5.57%
Top 10 Hldgs %
81.99%
Holding
44
New
1
Increased
4
Reduced
3
Closed
5

Top Buys

Rank Stock Value
1
ALPN
Alpine Immune Sciences Inc
ALPN
+$2.24M
2
GERN icon
Geron
GERN
+$992K
3
LONA
LeonaBio Inc
LONA
+$431K
4
KALV
KalVista Pharmaceuticals
KALV
+$305K
5
CABA icon
Cabaletta Bio
CABA
+$82.4K

Top Sells

Rank Stock Value
1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$4.41M
2
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
+$4.38M
3
OCS icon
Oculis Holding
OCS
+$557K
4
GTLB icon
GitLab
GTLB
+$353K
5
MRUS
Merus
MRUS
+$339K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
2 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMEA icon
26
Biomea Fusion
BMEA
$91.3M
$550K 0.45%
40,000
– –
DBVT
27
DBV Technologies
DBVT
$847M
$504K 0.41%
37,095
– –
LONA
28
LeonaBio Inc
LONA
$72.1M
$364K 0.29%
18,000
+16,823
+1,429% +$431K
EAR
29
DELISTED
Eargo, Inc. Common Stock
EAR
$321K 0.26%
147,904
– –
BMRN icon
30
BioMarin Pharmaceuticals
BMRN
$12.4B
$320K 0.26%
3,615
– –
AKRO
31
DELISTED
Akero Therapeutics
AKRO
$224K 0.18%
4,425
– –
ALXO icon
32
ALX Oncology
ALXO
$290M
$201K 0.16%
41,950
– –
AFMD
33
DELISTED
Affimed
AFMD
$178K 0.14%
37,247
– –
BCRX icon
34
BioCryst Pharmaceuticals
BCRX
$2.4B
$126K 0.1%
17,847
– –
GRTX
35
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$107K 0.09%
613,223
– –
ABCL icon
36
AbCellera Biologics
ABCL
$2.12B
$57.6K 0.05%
12,521
– –
KYNB
37
Kyntra Bio
KYNB
$29.4M
$53.6K 0.04%
2,484
– –
KOD icon
38
Kodiak Sciences
KOD
$2.84B
$35.3K 0.03%
19,622
– –
CERS icon
39
Cerus
CERS
$474M
$23K 0.02%
14,172
– –
GTLB icon
40
GitLab
GTLB
$6.58B
– –
-6,910
Closed -$353K
MDGL icon
41
Madrigal Pharmaceuticals
MDGL
$11.8B
– –
-1,182
Closed -$273K
RETA
42
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-3,300
Closed -$336K
KDNY
43
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
– –
-113,950
Closed -$4.38M
ISEE
44
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-111,984
Closed -$4.41M
1
2

Similar funds

MAM
Mirabaud Asset Management London, United Kingdom $121M AUM 20.69% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
CCM
Candelo Capital Management New York $121M AUM 113.39% 1-Year Est. Return
CCM
CFO Capital Management Fairfield, Connecticut $121M AUM
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
MW
Merited Wealth North Bay Village, Florida $121M AUM

Nan Fung Group Holdings's Q3 2023 Portfolio in Review

As of Q3 2023, Nan Fung Group Holdings held 44 positions worth $123M, down 21% from $156M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Nan Fung Group Holdings withdrew a net $6.88M in Q3 2023, closing 5 positions and reducing 3 holdings. Its most notable exit was IVERIC bio, Inc. Common Stock, an estimated $4.41M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 100% a quarter earlier, followed by Technology.

Against the trend, Nan Fung Group Holdings opened a new position in Alpine Immune Sciences Inc worth $2.09M.

  • Nan Fung Group Holdings's largest Q3 2023 buy was Alpine Immune Sciences Inc: 182,280 shares worth $2.09M.
  • Nan Fung Group Holdings added most to Geron in Q3 2023, an estimated $992K increase.
  • Nan Fung Group Holdings's biggest Q3 2023 reduction was Oculis Holding, cutting an estimated $557K.
  • Nan Fung Group Holdings fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $4.41M.
  • Nan Fung Group Holdings's ten largest holdings make up 82% of its $123M portfolio in Q3 2023.
  • Nan Fung Group Holdings opened 1 new position and closed 5 in Q3 2023.
  • Nan Fung Group Holdings's portfolio value fell 21% quarter-over-quarter to $123M.

Based on Nan Fung Group Holdings's 13F filing for Q3 2023, filed 13 Nov 2023.